Boston Partners
SEM

Boston Partners’s Select Medical SEM Stock Holding History

Boston Partners’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-44,193
Closed -$718K – 782
2024
Q1 		$718K Buy
+44,193
New +$647K ﹤0.01% 634
2020
Q1 		– Sell
-148
Closed -$2K – 730
2019
Q4 		$2K Hold
148
– – ﹤0.01% 698
2019
Q3 		$1K Buy
+148
New +$1.29K ﹤0.01% 710
2018
Q4 		– Sell
-1,583,456
Closed -$15.7M – 742
2018
Q3 		$15.7M Sell
1,583,456
-38,588
-2% -$400K 0.02% 345
2018
Q2 		$15.9M Buy
1,622,044
+23,768
+1% +$233K 0.02% 348
2018
Q1 		$14.9M Sell
1,598,276
-64,793
-4% -$617K 0.02% 346
2017
Q4 		$15.8M Buy
1,663,069
+118,790
+8% +$1.14M 0.02% 339
2017
Q3 		$16M Sell
1,544,279
-1,429,837
-48% -$13.2M 0.02% 338
2017
Q2 		$24.6M Buy
2,974,116
+78,233
+3% +$587K 0.03% 297
2017
Q1 		$20.8M Sell
2,895,883
-20,457
-0.7% -$148K 0.03% 316
2016
Q4 		$20.8M Buy
2,916,340
+269
+0% +$1.87K 0.03% 326
2016
Q3 		$21.2M Buy
2,916,071
+162,699
+6% +$1.03M 0.03% 309
2016
Q2 		$16.1M Buy
2,753,372
+27,140
+1% +$180K 0.02% 340
2016
Q1 		$17.3M Buy
2,726,232
+21,684
+0.8% +$116K 0.03% 313
2015
Q4 		$17.4M Buy
2,704,548
+134,411
+5% +$840K 0.02% 321
2015
Q3 		$14.9M Buy
2,570,137
+48,512
+2% +$360K 0.02% 336
2015
Q2 		$22M Buy
2,521,625
+292,307
+13% +$2.45M 0.03% 289
2015
Q1 		$17.8M Sell
2,229,318
-112,195
-5% -$838K 0.03% 316
2014
Q4 		$18.2M Sell
2,341,513
-2,380,903
-50% -$17.4M 0.03% 316
2014
Q3 		$30.6M Buy
4,722,416
+473,763
+11% +$3.66M 0.05% 245
2014
Q2 		$35.7M Sell
4,248,653
-646,525
-13% -$5.01M 0.06% 226
2014
Q1 		$32.8M Buy
4,895,178
+648,750
+15% +$3.93M 0.06% 230
2013
Q4 		$26.6M Buy
4,246,428
+167,684
+4% +$819K 0.05% 247
2013
Q3 		$17.7M Buy
4,078,744
+1,175,539
+40% +$5.37M 0.04% 274
2013
Q2 		$12.8M Buy
+2,903,205
New +$12.9M 0.04% 308

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boston Partners's SEM Position: Q2 2024 in Review

Boston Partners sold out of Select Medical (SEM) in Q2 2024, closing a stake of 44,193 shares — an estimated $718K sold.

Boston Partners first reported a position in SEM in Q2 2013 and held it in 25 quarters. The position peaked at $35.7M in Q2 2014. 256 funds tracked by Wall St. Rank hold SEM as of Q2 2024.

  • Boston Partners reported no remaining Select Medical position as of Q2 2024 after selling out during the quarter.
  • Boston Partners sold 44,193 Select Medical shares in Q2 2024, an estimated $718K.
  • Boston Partners first reported a position in Select Medical in Q2 2013 and held it in 25 quarters.
  • Boston Partners's Select Medical position peaked at $35.7M in Q2 2014.
  • 256 funds tracked by Wall St. Rank held Select Medical as of Q2 2024.

Based on Boston Partners's 13F filing for Q2 2024, filed 14 Aug 2024.